Properties of volume-regulated anion channels in mammalian cells B Nilius, J Eggermont, T Voets, G Buyse, V Manolopoulos, G Droogmans Progress in biophysics and molecular biology 68 (1), 69-119, 1997 | 423 | 1997 |
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ... New England Journal of Medicine 369 (24), 2304-2312, 2013 | 261 | 2013 |
Genetic polymorphisms of drug‐metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population K Arvanitidis, G Ragia, M Iordanidou, S Kyriaki, A Xanthi, A Tavridou, ... Fundamental & clinical pharmacology 21 (4), 419-426, 2007 | 187 | 2007 |
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice A Squassina, M Manchia, VG Manolopoulos, M Artac, C Lappa-Manakou, ... Pharmacogenomics 11 (8), 1149-1167, 2010 | 181 | 2010 |
Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins T Voets, V Manolopoulos, J Eggermont, C Ellory, G Droogmans, B Nilius The Journal of Physiology 506 (Pt 2), 341, 1998 | 181 | 1998 |
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design RMF Van Schie, MIA Wadelius, F Kamali, AK Daly, VG Manolopoulos, ... Pharmacogenomics 10 (10), 1687-1695, 2009 | 168 | 2009 |
A global view of the OCA2-HERC2 region and pigmentation MP Donnelly, P Paschou, E Grigorenko, D Gurwitz, C Barta, RB Lu, ... Human genetics 131, 683-696, 2012 | 166 | 2012 |
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education D Gurwitz, JE Lunshof, G Dedoussis, CS Flordellis, U Fuhr, J Kirchheiner, ... The pharmacogenomics journal 5 (4), 221-225, 2005 | 145 | 2005 |
Presence of CYP2C9*3 Allele Increases Risk for Hypoglycemia in Type 2 Diabetic Patients Treated with Sulfonylureas G Ragia, I Petridis, A Tavridou, D Christakidis, VG Manolopoulos Pharmacogenomics 10 (11), 1781-1787, 2009 | 118 | 2009 |
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies G Ragia, VG Manolopoulos European journal of clinical pharmacology 76, 1623-1630, 2020 | 115 | 2020 |
The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis C Staikos, A Ververidis, G Drosos, VG Manolopoulos, DA Verettas, ... Rheumatology 52 (6), 1077-1083, 2013 | 113 | 2013 |
Characterisation of explanted endothelial cells from mouse aorta: electrophysiology and Ca2+ signalling SH Suh, R Vennekens, VG Manolopoulos, M Freichel, U Schweig, ... Pflügers Archiv 438, 612-620, 1999 | 100 | 1999 |
Pharmacogenetics of coumarinic oral anticoagulants VG Manolopoulos, G Ragia, A Tavridou Pharmacogenomics 11 (4), 493-496, 2010 | 97 | 2010 |
Cardioprotection by H2S donors: nitric oxide-dependent and‑independent mechanisms A Chatzianastasiou, SI Bibli, I Andreadou, P Efentakis, N Kaludercic, ... Journal of Pharmacology and Experimental Therapeutics 358 (3), 431-440, 2016 | 93 | 2016 |
Need for Reassessment of Reported CYP2C19 Allele Frequencies in Various Populations in View of CYP2C19*17 Discovery: The Case of Greece G Ragia, KI Arvanitidis, A Tavridou, VG Manolopoulos Pharmacogenomics 10 (1), 43-49, 2009 | 92 | 2009 |
Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective VG Manolopoulos, G Ragia, A Tavridou Pharmacogenomics 12 (8), 1161-1191, 2011 | 87 | 2011 |
The distribution and most recent common ancestor of the 17q21 inversion in humans MP Donnelly, P Paschou, E Grigorenko, D Gurwitz, SQ Mehdi, ... The American Journal of Human Genetics 86 (2), 161-171, 2010 | 84 | 2010 |
The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes M Iordanidou, A Tavridou, I Petridis, KI Arvanitidis, D Christakidis, ... Clinica Chimica Acta 411 (3-4), 167-171, 2010 | 83 | 2010 |
Expression patterns of sarco/endoplasmic reticulum Ca2+-ATPase and inositol 1, 4, 5-trisphosphate receptor isoforms in vascular endothelial cells I Mountian, VG Manolopoulos, H De Smedt, JB Parys, L Missiaen, ... Cell Calcium 25 (5), 371-380, 1999 | 82 | 1999 |
Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress L Mazzolai, P Silacci, K Bouzourene, F Daniel, H Brunner, D Hayoz Thrombosis and haemostasis 87 (06), 1062-1068, 2002 | 73 | 2002 |